Economic evaluation of therapeutic education (in diabetes school) for patients with type 1 and type 2 diabetes mellitus

Fedyaeva V.K.; Omelyanovskiy V.V.; Sukhorukikh O.A.; Ryzhov A.O.; Mochalova A.A.

doi:https://doi.org/10.17116/medtech20224401123

Fedyaeva V.K.

Center for Expertise and Quality Control of Medical Care;
Financial Research Institute

SPIN RSCI: 7202-4371
ORCID: 0000-0002-7730-1237

Omelyanovskiy V.V.

Center for Expertise and Quality Control of Medical Care;
Russian Medical Academy of Continuous Professional Education;
Research Financial Institute;
Semashko National Research Institute of Public Health

ORCID: 0000-0003-1581-0703

Sukhorukikh O.A.

Center for Expertise and Quality Control of Medical Care;
Financial Research Institute

Ryzhov A.O.

Center for Expertise and Quality Control of Medical Care

SPIN RSCI: 7983-4460
ORCID: 0000-0001-9313-2122

Mochalova A.A.

Center for Expertise and Quality Control of Medical Care

Economic evaluation of therapeutic education (in diabetes school) for patients with type 1 and type 2 diabetes mellitus

Authors:

Fedyaeva V.K., Omelyanovskiy V.V., Sukhorukikh O.A., Ryzhov A.O., Mochalova A.A.

More about the authors

Journal: Medical Technologies. Assessment and Choice. 2022;44(1): 23‑33

DOI: 10.17116/medtech20224401123

Read: 2154 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Fedyaeva VK, Omelyanovskiy VV, Sukhorukikh OA, Ryzhov AO, Mochalova AA. Economic evaluation of therapeutic education (in diabetes school) for patients with type 1 and type 2 diabetes mellitus. Medical Technologies. Assessment and Choice. 2022;44(1):23‑33. (In Russ.)
https://doi.org/10.17116/medtech20224401123

Подписка 2026 Медицинские технологии. Оценка и выбор (Medical Technologies. Assessment and Choice)

Использование инфографики авторами научных работ

Close metadata

ABSRACT

Diabetes mellitus (DM) is one of the leading causes of mortality in the world and in the Russian Federation. According to available data, therapeutic education of patients with DM in specially organized schools is an important and effective measure of medical care increasing duration and quality of life. Currently, there are no data on the cost-effectiveness of diabetes schools for patients with DM in the Russian Federation.

OBJECTIVE

To evaluate clinical and economic feasibility of therapeutic education (diabetes school) in adults with type 1 and type 2 diabetes mellitus in the Russian Federation.

MATERIAL AND METHODS

The cost-effectiveness analysis was carried out. We have modeled the number of complications of DM depending on glycated hemoglobin either at the end of therapeutic education or without education. The costs of diabetes schools and in-hospital treatment of DM-associated complications were calculated from the perspective of compulsory health insurance system for a 10-year period. We used the register of DM patients for 2015-2019 provided by the National Medical Research Center for Endocrinology and clinical trials of therapeutic education of these patients.

RESULTS

Therapeutic education of patients with type 1 and type 2 diabetes mellitus reduces the number of complications, mortality and treatment cost after 5-year period.

CONCLUSION

Therapeutic education (diabetes schools) is cost-effective in our study for both type 1 and type 2 diabetes mellitus.

Keywords:

cost-effectiveness analysis

diabetes mellitus

diabetes school

therapeutic education

life years gained

glycated hemoglobin

HbA1c

Authors:

Fedyaeva V.K.

Center for Expertise and Quality Control of Medical Care;
Financial Research Institute

SPIN RSCI: 7202-4371
ORCID: 0000-0002-7730-1237

Omelyanovskiy V.V.

ORCID: 0000-0003-1581-0703

Sukhorukikh O.A.

Center for Expertise and Quality Control of Medical Care;
Financial Research Institute

Ryzhov A.O.

Center for Expertise and Quality Control of Medical Care

SPIN RSCI: 7983-4460
ORCID: 0000-0001-9313-2122

Mochalova A.A.

Center for Expertise and Quality Control of Medical Care

Received:

02.12.2021

Accepted:

27.01.2022

Close metadata

References:

World Health Organization. Diabetes. Accessed July 19,2021. https://www.who.int/news-room/fact-sheets/detail/diabetes
World Health Organization. WHO reveals leading causes of death and disability worldwide: 2000-2019. Accessed November 10, 2021. https://www.who.int/news/item/09-12-2020-who-reveals-leading-causes-of-death-and-disability-worldwide-2000-2019
Vsemirnaya organizatsiya zdravookhraneniya. 10 vedushchikh prichin smerti v mire. Accessed November 10, 2021. (In Russ.). https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causes-of-death
Dedov II, Shestakova MV, Vikulova OK. Epidemiology of diabetes mellitus in Russian Federation: clinical and statistical report according to the federal diabetes registry. Sakharnyj diabet. 2017; 20(1):13-41. (In Russ.). https://doi.org/10.14341/DM8664
Vsemirnaya organizatsiya zdravookhraneniya. Global’nyj doklad po diabetu. Accessed July 19, 2021. (In Russ.). https://edu.volgmed.ru/pluginfile.php/38294/mod_resource/content/1/%D0%94%D0%B8%D0%B0%D0%B1%D0%B5%D1%822018.pdf
Baghianimoghadam MH, Hadavandkhani M, Mohammadi M, Fallahzade H, Baghianimoghadam B. Current education versus peer-education on walking in type 2 diabetic patients based on Health Belief Model: a randomized control trial study. Romanian Journal of Internal Medicine. 2012;50(2):165-172.
Adolfsson ET, Walker-Engström M-L, Smide B, Wikblad K. Patient education in type 2 diabetes — a randomized controlled 1-year follow-up study. Diabetes Research and Clinical Practice. 2007; 76(3):341-350. https://doi.org/10.1016/j.diabres.2006.09.018
DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. British Medical Journal. 2002;325(7367):746. https://doi.org/10.1136/bmj.325.7367.746
Zoffmann V, Lauritzen T. Guided self-determination improves life skills with type 1 diabetes and A1C in randomized controlled trial. Patient Education and Counseling. 2006;64(1-3):78-86. https://doi.org/10.1016/j.pec.2005.11.017
Ehrmann D, Kulzer B, Schipfer M, Lippmann-Grob B, Haak T, Hermanns N. Efficacy of an education program for people with diabetes and insulin pump treatment (INPUT): results from a randomized controlled trial. Diabetes Care. 2018;41(12):2453-2462. https://doi.org/10.2337/dc18-0917
Amendezo E, Walker Timothy D, Karamuka V, Robinson B, Kavabushi P, Ntirenganya C, et al. Effects of a lifestyle education program on glycemic control among patients with diabetes at Kigali University Hospital, Rwanda: A randomized controlled trial. Diabetes Research and Clinical Practice. 2017;126:129-137. https://doi.org/10.1016/j.diabres.2017.02.001
Piatt GA, Anderson RM, Brooks MM, Songer T, Siminerio LM, Korytkowski MM, et al. 3-year follow-up of clinical and behavioral improvements following a multifaceted diabetes care intervention. The Diabetes Educator. 2010;36(2):301-309. https://doi.org/10.1177/0145721710361388
Sadur CN, Moline N, Costa M, Michalik D, Mendlowitz D, Roller S, et al. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care. 1999;22(12):2011-2017. https://doi.org/10.2337/diacare.22.12.2011
Rygg LØ, Rise MB, Grønning K, Steinsbekk A. Efficacy of ongoing group based diabetes self-management education for patients with type 2 diabetes mellitus. A randomised controlled trial. Patient Education and Counseling. 2012;86(1):98-105. https://doi.org/10.1016/j.pec.2011.04.008
Deakin TA, Cade JE, Williams R, Greenwood DC. Structured patient education: The Diabetes X‐PERT Programme makes a difference. Diabetic Medicine. 2006;23(9):944-954. https://doi.org/10.1111/j.1464-5491.2006.01906.x
Menard J, Payette H, Dubuc N, Baillargeon JP, Maheux P, ArdilouzeJL. Quality of life in type 2 diabetes patients under intensive multitherapy. Diabetes and Metabolism. 2007;33(1):54-60. https://doi.org/10.1016/j.diabet.2006.09.001
Ménard J, Payette H, Baillargeon JP, Maheux P, Lepage S, Tessier D, et al. Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: A randomized controlled trial. CMAJ. 2005; 173:1457-1466. https://doi.org/10.1016/j.diabet.2006.09.001
Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. British Medical Journal. 2008;336 (7642):491-495. https://doi.org/10.1136/bmj.39474.922025.BE
Khunti K, Gray LJ, Skinner T, Carey ME, Realf K, Dallosso H, et al. Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. British Medical Journal. 2012;344:e2333. https://doi.org/10.1136/bmj.e2333
Price KJ, Knowles JA, Fox M, Wales JK, Heller S, Eiser C, et al. Effectiveness of the Kids in Control of Food (KICk-OFF) structured education course for 11-16 year olds with Type 1 diabetes. Diabetic Medicine. 2016;33(2):192-203. https://doi.org/10.1111/dme.12881
Christie D, Thompson R, Sawtell M, Allen E, Cairns J, Smith F, et al. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: A cluster randomised controlled trial with integral process and economic evaluation-the CASCADE study. Health Technology Assessment. 2014;18(20):1-202. https://doi.org/10.3310/hta18200
Shitkovskaya EP, Starykh EF, Strelnikov GYu, Dmitriev SI, Strelnikov AG. The effectiveness of the “School of diabetes mellitus”. Voprosy sovremennoj pediatrii. 2006;5(1)S:666a. (In Russ.).
Svetyy LI, Vorvul AO, Markina EV, Ivikh KA, Russu AA. Results of study at the diabetes school of elderly people suffering from type II diabetes. Sovremennye problemy zdravookhraneniya i meditsinskoj statistiki. 2020;1:82-91. (In Russ.).
Mash R, Kroukamp R, Gaziano T, Levitt N. Cost-effectiveness of a diabetes group education program delivered by health promoters with a guiding style in underserved communities in Cape Town, South Africa. Patient Education and Counseling. 2015;98(5): 622-626. https://doi.org/10.1016/j.pec.2015.01.005
Lian J, McGhee SM, So C, Chau J, Wong CK, Wong WC, et al. Long‐term cost‐effectiveness of a Patient Empowerment Programme for type 2 diabetes mellitus in primary care. Diabetes, Obesity and Metabolism. 2019;21(1):73-83. https://doi.org/10.1111/dom.13485
Gillett M, Dallosso HM, Dixon S, Brennan A, Carey ME, Campbell MJ, et al. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: Cost effectiveness analysis. BMJ. 2010;341(7770):1-10. https://doi.org/10.1136/bmj.c4093
Kruger J, Brennan A, Thokala P, Basarir H, Jacques R, Elliott J, et al. The cost-effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy Model. Diabetic Medicine. 2013;30(10):1236-1244. https://doi.org/10.1111/dme.12270
ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine. 2008;358(24):2560-2572. https://doi.org/10.1056/NEJMoa0802987
Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329(14): 977-986. https://doi.org/10.1001/archinternmed.2011.16
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New England Journal of Medicine. 2005;353(25):2643-2653. https://doi.org/10.2337/dc15-1990
Health Quality Ontario. Continuous monitoring of glucose for type 1 diabetes: a health technology assessmen. Ontario Health Technology Assessment Series. 2018;18(2):1-160.
National Kidney Foundation. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. American Journal of Kidney Diseases. 2015;66(5):884-930. https://doi.org/10.1053/j.ajkd.2015.07.015
Metodicheskie rekomendatsii po provedeniyu sravnitel’noj kliniko-ekonomicheskoj otsenki lekarstvennogo preparata (novaya redaktsiya). M.: FGBU «TsEKKMP» Minzdrava Rossii»; 2018. Accessed May 19,2021. (In Russ.). https://rosmedex.ru/wp-content/uploads/2019/06/MR-KE%60I_novaya-redaktsiya_2018-g.pdf
Bezdenezhnykh TP, Omelyanovskiy VV, Musina NZ, Fedyaeva VK, Teptsova TS. Theoretical approaches to determining the threshold of willingness to pay for healthcare technologies Theoretical approaches to determining the threshold of willingness to pay for healthcare technologies. Pharmacy. 2018;67(8):9-15. (In Russ.). https://doi.org/10.29296/25419218-2018-08-02
Zelenova OV. Modern methods of studying the threshold of willingness to pay in the healthcare sector. Menedzher zdravookhraneniya. 2011;6:61-69. (In Russ.).